Nothing new on Exact Sciencesin the last three months. We read the news on it every day, write up anything that matters once a week, and tell you sooner if something can't wait. A quiet stretch is normal and is not a signal by itself.
Exact Sciences analyst price targets
Average target$92.95-11%vs $104.91 today
Avg price
Low $46High $135
Buy41 analysts
2Bearish
17Neutral
22Bullish
FirmRatingPrice TargetDate
Mizuho Securities
Neutral
$105
1/20/2026
Evercore ISI
In Line
$105
1/5/2026
Stifel Nicolaus
Hold
$105
11/28/2025
Canaccord Genuity
Hold
$105
11/25/2025
Piper Sandler
Overweight
$105
11/24/2025
Jefferies
Hold
$105
11/24/2025
Craig-Hallum
Buy
$105
11/21/2025
Barclays
Equal Weight
$105
11/20/2025
Wells Fargo
Equal Weight
$105
11/20/2025
Robert W. Baird
Outperform
$105
11/20/2025
Robert W. Baird
Outperform
$72→$88
11/4/2025
BTIG
Neutral
$75→$85
11/4/2025
Exact Sciences earnings
The company has a choppy track record, with several large misses over the last two years. This makes it harder to trust that management has a perfect handle on near-term results.
Earnings history
EstimateBeatMiss
Exact Sciences past earnings results
Expected
Actual
Surprise
EPS
$-0.11
$-0.45
-316.9%
Revenue
$861M
$878M
+2.0%
Metrics we are tracking
Metric
Expectations
Status
Screening Revenue Growth
Sustaining growth above 15% annually
20% YoY in Q3 2025
Free Cash Flow
Reaching $400 million or more annually
$360M in FY2025
Gross Margin
Staying above 68% for all diagnostic products
69.7% as of FY2025
GAAP Net Income
Turning positive by the end of FY2026
-$0.10 EPS in Q3 2025
Stay on top of Exact Sciences
Follow Exact Sciences to get the latest and most important updates.